Herantis Pharma doses final cohort in phase 1b trial of HER-096 for Parkinson’s disease - PharmaTimes Trial progresses towards topline data expected later in the year

#HerantisPharma #phase1btrial #HER096 #Parkinsonsdisease #clinicaltrial #drugsafety #tolerability #pharmacokinetics #biomarkers #syntheticpeptidomimetic #cerebraldopamineneurotropicfactorprotein #CDNFprotein #MichaelJFoxFoundationforParkinsonsResearch #ParkinsonsUK
pharmatimes.com/news/heranti...